Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The relationship between methionine synthase rs1805087 polymorphism and hematological cancers risk.

Future oncology (London, England) - 1 Oct 2020

Bai Yanliang, Drokow Emmanuel Kwateng, Waqas Ahmed Hafiz Abdul, Song Juanjuan, Akpabla Gloria Selorm, Kumah Maame Awoyoe, Agyekum Emmanuel Bamfo, Neku Enyonam Adjoa, Sun Kai

Abstract excerpt

Background: The relationship between hematological cancer susceptibility and methionine synthase MTR A2756G (rs1805087) polymorphism is inconclusive based on data from past studies. Hence, this updated meta-analysis was conducted to investigate the relationship between methionine synthase reductase (MTR) rs1805087 polymorphism and hematological cancers. Method: We searched EMBASE, Google Scholar, Ovid and PubMed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase
Share to Case-Control Studies
Share to Genetic Association Studies
Share to Hematologic Neoplasms
Share to Odds Ratio
Share to Publication Bias
Share to Risk Assessment
Share to Risk Factors

Source

Identifiers

PMID: 32722923
DOI: 10.2217/fon-2020-0627

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The relationship between methionine synthase rs1805087 polymorphism and hematological cancers risk.PMID 32722923Read ↗

The association between methionine synthase A2756G polymorphism and hematological cancer: A meta-analysis.Semantic proximity Read ↗

Methionine synthase A2756G polymorphism and cancer risk: a meta-analysis.Semantic proximity Read ↗

Methionine synthase A2756G polymorphism and lymphoma risk: a meta-analysis.Semantic proximity Read ↗

Lack of association between methionine synthase A2756G polymorphism and digestive system cancer risk: evidence from 3,9327 subjects.Semantic proximity Read ↗

The relationship between methylenetetrahydrofolate reductase polymorphism and hematological malignancy.Semantic proximity Read ↗

Impact of Methionine Synthase Reductase Polymorphisms in Chronic Myeloid Leukemia Patients.Semantic proximity Read ↗

Update meta-analysis from biomedical literature about MTHFR'polymorphisms and the CML' risk.Semantic proximity Read ↗

Methionine synthase reductase A66G polymorphism and leukemia risk: evidence from published studies.Semantic proximity Read ↗

Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case-control studies.Semantic proximity Read ↗

Methylenetetrahydrofolate reductase gene polymorphisms contribute to acute myeloid leukemia and chronic myeloid leukemia susceptibilities: evidence from meta-analyses.Semantic proximity Read ↗

Methionine synthase genetic polymorphism MS A2756G alters susceptibility to follicular but not diffuse large B-cell non-Hodgkin's lymphoma or multiple myeloma.Semantic proximity Read ↗

No association between MTR rs1805087 A > G polymorphism and non-Hodgkin lymphoma susceptibility: evidence from 11 486 subjects.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.